ENHABIT INC: UBS Increases Target Price from $12 to $13.8
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
Should l Buy EHAB?
Source: moomoo
- UBS Raises Target Price: UBS has increased its target price for a specific asset from $12 to $13.8.
- Market Implications: This adjustment reflects UBS's confidence in the asset's performance and potential growth in the market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EHAB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EHAB
Wall Street analysts forecast EHAB stock price to fall
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 13.600
Low
10.50
Averages
12.20
High
14.00
Current: 13.600
Low
10.50
Averages
12.20
High
14.00
About EHAB
Enhabit, Inc. is a provider of home health and hospice services in the United States. Its segments include Home Health and Hospice. The Home Health segment provides a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. It works closely with patients, families, caregivers, and physicians to deliver data-driven, evidence-based care plans focused on patient needs and goals. Its home health services are provided by nurses, physical, occupational and speech therapists, medical social workers, and home health aides. The Hospice segment provides hospice services to terminally ill patients and their families. Hospice care focuses on the quality of life for patients experiencing an advanced, life- limiting illness by treating the symptoms of the disease, rather than the disease itself. It operates about 115 hospice agencies and 255 home health agencies.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- New Investment Position: AREX Capital Management disclosed in a February 17, 2026 SEC filing that it established a new position in Callaway Golf Company by acquiring 453,000 shares, valued at an estimated $5.29 million, indicating confidence in the company's prospects.
- Significant Holding Proportion: This acquisition positions Callaway to account for 15.03% of AREX's reportable 13F assets, marking its importance within the fund's top five holdings, which may influence future investment strategies.
- Strong Stock Performance: As of February 28, 2026, Callaway shares were priced at $14.06, reflecting a 115.3% increase over the past year, significantly outperforming the S&P 500 by 99.78 percentage points, suggesting optimistic market sentiment regarding its recovery.
- Strategic Restructuring Signal: Following the merger with Topgolf, Leonard Green & Partners acquired a 60% stake in Topgolf in early 2026, and this spinoff aims to help Callaway sharpen its strategic focus, indicating potential for future growth despite inherent risks.
See More
- New Investment Position: On February 17, 2026, AREX Capital Management established a new position in Callaway Golf Company by acquiring 453,000 shares valued at $5.29 million, representing 15.03% of its reportable 13F assets.
- Portfolio Structure Shift: This acquisition positions Callaway as the second-largest holding for AREX, following EHAB, which is valued at $22.99 million and constitutes 65.36% of its AUM, reflecting AREX's confidence in the golf sector.
- Stock Price Recovery: As of February 28, 2026, Callaway's stock price reached $14.06, marking a 115.3% increase over the past year and outperforming the S&P 500 by 99.78 percentage points, indicating optimistic market expectations for future growth.
- Strategic Restructuring Signal: Following its merger with Topgolf in 2021, the acquisition of a 60% stake in Topgolf by Leonard Green & Partners in early 2026 suggests that Callaway is focusing on core operations, potentially enhancing growth prospects, although structural changes may lead to increased volatility.
See More
- UBS Raises Target Price: UBS has increased its target price for a specific asset from $12 to $13.8.
- Market Implications: This adjustment reflects UBS's confidence in the asset's performance and potential growth in the market.
See More
- Acquisition Proposal Investigation: Former Louisiana Attorney General Charles C. Foti and his law firm Kahn Swick & Foti are investigating the proposed sale of Enhabit, Inc. (NYSE: EHAB) to Kinderhook Industries, aiming to assess the adequacy of the transaction.
- Cash Acquisition Price: Under the proposal, Enhabit shareholders are set to receive $13.80 per share in cash, with the investigation focusing on whether this price adequately reflects the company's true value.
- Legal Rights Consultation: KSF encourages shareholders who believe the transaction undervalues the company to reach out for legal consultation, emphasizing the importance of protecting shareholder rights and ensuring transparency in the transaction process.
- Potential Impact Assessment: This investigation may affect shareholder confidence in Enhabit and market expectations regarding its future value, reflecting a cautious approach to the acquisition process that could lead to a reassessment of the transaction terms by shareholders.
See More
- Investigation Focus: Halper Sadeh LLC is investigating Arcellx, Inc. (NASDAQ:ACLX) for potential fiduciary duty breaches related to its sale to Gilead Sciences, Inc. for $115.00 per share in cash plus a $5.00 contingent value right, which may disadvantage shareholders.
- Shareholder Rights: Veris Residential, Inc. (NYSE:VRE) is being sold to an investor consortium led by Affinius Capital for $19.00 per share, and Halper Sadeh LLC encourages shareholders to contact them to understand their rights and options, potentially impacting financial outcomes.
- Potential Compensation: United Homes Group, Inc. (NASDAQ:UHG) is selling to Stanley Martin Homes, LLC for $1.18 per share in cash, with Halper Sadeh LLC possibly seeking increased consideration and additional disclosures to protect shareholder interests.
- Legal Support: Enhabit, Inc. (NYSE:EHAB) is being sold to Kinderhook Industries, LLC for $13.80 per share in cash, and Halper Sadeh LLC offers no-cost legal consultations to help shareholders address potential securities fraud and corporate misconduct issues.
See More
- Investigation Launched: Halper Sadeh LLC is investigating the acquisition of Enhabit, Inc. by Kinderhook Industries at a price of $13.80 per share, raising concerns about potential impacts on shareholder rights.
- Legal Compliance Review: The investigation focuses on whether Enhabit and its board violated federal securities laws by failing to secure the best possible price for shareholders, potentially harming their interests.
- Sales Process Transparency: Halper Sadeh highlights whether there were conflicts of interest in the sales process and if all material information was disclosed, which could affect shareholders' evaluation of the transaction.
- Shareholder Rights Protection: The law firm may seek increased consideration, additional disclosures, or other relief on behalf of shareholders to safeguard their legal rights.
See More






